top glp-1 medications for weight loss 2025 Market Overview: Agonists and the Obesity Market | Blog The Best GLP-1 Supplements for

64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending

It was very loosey goosy as to how you get the drug

FDA approves Ozempic (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease [press release]

Medicare savings and payments to manufacturers would get larger over time as more obesity-related conditions are avoided, with the largest savings coming from reductions in diabetes